Skip to content

New and upcoming biosimilar launches

The U.S. Generic & Biosimilar Medicines Savings Report (Sep. 2022)

National trends in prescription drug expenditures and projections for 2022

The Complexities of Biosimilars and the Regulatory Approval Process

Cost Savings with Biosimilars in Rheumatology: A Systematic Literature Search of Budget Impact Analysis

A health economic guide to market access of biosimilars

Assessing the Value of Biosimilars: A Review of the Role of Budget Impact Analysis

Overcoming barriers to biosimilar adoption: real-world perspectives from a national payer and provider initiative

Factors influencing the economics of biosimilars in the US

Barriers to Oncology Biosimilars Update in the United States (The Oncologist)